cepharanthine has been researched along with Cancer of Mouth in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferdous, T; Harada, K; Itashiki, Y; Mano, T; Mori, Y; Takii, M; Ueyama, Y | 2 |
| Harada, K; Harada, T; Ueyama, Y | 1 |
| Azuma, M; Bando, T; Kawashima, Y; Motegi, K; Takamaru, N; Tamatani, T | 1 |
4 other study(ies) available for cepharanthine and Cancer of Mouth
| Article | Year |
|---|---|
Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzylisoquinolines; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoenzyme Techniques; In Situ Nick-End Labeling; Male; Mice; Mice, Nude; Mouth Neoplasms; Orotate Phosphoribosyltransferase; Oxonic Acid; Tegafur; Thymidylate Synthase; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |
Cepharanthine inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing expression of vascular endothelial growth factor and interleukin-8.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Blotting, Western; Carcinoma, Squamous Cell; Cell Movement; Cell Proliferation; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Interleukin-8; Mice; Mice, Nude; Mouth Neoplasms; Neovascularization, Pathologic; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2009 |
The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; DNA Repair; DNA Repair Enzymes; Female; Humans; Mice; Mice, Nude; Mouth Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Statistics, Nonparametric; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Topics: Alkaloids; Animals; Apoptosis; Benzylisoquinolines; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Fluorescent Antibody Technique; Gamma Rays; Humans; I-kappa B Kinase; Inhibitor of Apoptosis Proteins; Interleukin-6; Interleukin-8; Luciferases; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; NF-kappa B; Radiation-Protective Agents; Radiation, Ionizing; RNA, Messenger | 2007 |